Douglas Faller

All filings by Douglas Faller on record concern Oryzon Genomics, S.A., in the capacity of chief executive. In total, 3 filings cover trades dated from 9 August 2022 to 6 February 2024.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 8 February 2024: a transaction of €16k, in Oryzon Genomics, S.A. The median gap between a trade and its publication by CNMV is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by CNMV and describes the past, not future prices; it is not investment advice.